Qin Sun

发表

Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (I) A Randomized Trial with PCSK9 Inhibitors

Yow-Ming C Wang, D. Strauss, M. Matta, 2022, Clinical pharmacology and therapeutics.

Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary

Yow-Ming C Wang, J. Polli, G. Lyman, 2022, Clinical pharmacology and therapeutics.

Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products

Yow-Ming C Wang, D. Strauss, M. Matta, 2022, Clinical pharmacology and therapeutics.

Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ‐1a Biologics

S. J. Schrieber, Yow-Ming C Wang, B. Rosenzweig, 2022, Clinical pharmacology and therapeutics.

Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins

Yow-Ming C Wang, Shiew-Mei Huang, Y. Hon, 2023, The AAPS Journal.

The combined analgesic, sedative, and anti-gastric cancer mechanisms of Tinospora sagittata var. yunnanensis (S. Y. Hu) H. S. Lo based on integrated ethnopharmacological data.

Qianqian Wang, Xiao-qin Wang, Yun Tang, 2022, Journal of ethnopharmacology.

Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (II) A Randomized Trial with IL‐5 Antagonists

Yow-Ming C Wang, D. Strauss, M. Matta, 2022, Clinical pharmacology and therapeutics.

Pharmacodynamic Biomarkers for Biosimilar Development and Approval: A Workshop Summary

S. J. Schrieber, Yow-Ming C Wang, D. Strauss, 2022, Clinical pharmacology and therapeutics.

Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary

Yow-Ming C Wang, J. Polli, G. Lyman, 2022, Clinical Pharmacology & Therapeutics.